China Biopharmaceuticals Holdings (OTC BB: CHBP) China Biopharmaceuticals Holdings is a vertically integrated pharmaceutical company dedicated to the discovery, development, manufacturing and marketing of small and large molecule pharmaceutical products, including medicines, vaccines, and active pharmaceutical ingredients for various categories of diseases. CHBP's product portfolio includes 260 drugs already approved for manufacturing and marketing by the Chinese State Food and Drug Administration (SFDA). CHBP also has submitted an additional 15 drug applications to the SFDA for its review. CHBP is a U.S.-listed public company with operating subsidiaries and senior management based in China. For further information, please visit our website at www.cbioinc.com.